Press Releases

Moderna, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that the Ministry of Food and Drug Safety of Korea (MFDS) has issued a marketing authorization for Spikevax®, Moderna's COVID-19 vaccine (mRNA-1273) manufactured by Samsung Biologics, a...

Pfizer Inc. and BioNTech SE announced that the U.S. FDA has expanded the Emergency Use Authorization (EUA) of a booster dose of the Pfizer-BioNTech COVID-19 vaccine to include individuals 16 years of age and older. The booster dose is...

Eli Lilly and Company and Regor Therapeutics Group have entered into a multi-year research collaboration and licensing agreement to discover, develop and commercialize novel therapies for metabolic disorders. Under the terms of the agreement, Lilly will have a license to...

Roche announced that the European Commission has extended the marketing authorisation for Actemra®/RoActemra® (tocilizumab) to include the treatment of COVID-19 in adults who are receiving systemic corticosteroids and require supplemental oxygen or mechanical ventilation.1 This decision comes just hours...

ATMPS Ltd/Hataali – a leader in blockchain-based data sharing platforms for advanced therapies – announces a new strategic partnership with Assurea LLC, the USA-based quality and compliance consultancy. The partnership will see Assurea and ATMPS offer a fully complaint plug...

Bachem, the Swiss-based biotechnology and pharmaceutical company, began laying the foundations for its biggest production site so far. The plant, in Bubendorf, Switzerland, will expand Bachem’s manufacturing capacity and provide the world’s most modern facility for producing peptides and...

Roquette, a global leader in plant-based ingredients and a leading provider of naturally-derived pharmaceutical excipients, announces its plans to open a new Innovation Center in the US to further the advancement of prescription drugs – and beyond. Located in...